Company intelligence / Profile preview

Shanghai Carnation Medical Technology

Shanghai, Shanghai Shi, Chinaprnewswire.com ↗

Ownership: Private
Development stage: Commercial

Overview

The company’s main product, the FUBA5200 Focused Ultrasound Body Contouring System, has been evaluated in a prospective multicenter randomized controlled clinical trial for noninvasive fat reduction. The study was recruiting as of April 2025; no published results are available yet.

Therapeutic areas: Dermatology
Modalities: Device (Focused ultrasound device)
Industry: Therapeutic Medical Devices

Partnerships

Synergies with CMS dermatology and medical aesthetic skin care product lines

Beyond the preview

Go deeper on Shanghai Carnation Medical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Carnation Medical Technology.

Explore the full profile